# Ologen® Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy

> **NCT03541551** · NA · COMPLETED · sponsor: **L.V. Prasad Eye Institute** · enrollment: 44 (actual)

## Conditions studied

- Primary Congenital Glaucoma
- Developmental Glaucoma
- Infantile Glaucoma

## Interventions

- **PROCEDURE:** CTT with ologen® Collagen Matrix
- **PROCEDURE:** Trab Trab

## Key facts

- **NCT ID:** NCT03541551
- **Lead sponsor:** L.V. Prasad Eye Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-13
- **Primary completion:** 2019-09-01
- **Final completion:** 2019-09-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2022-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03541551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03541551, "Ologen® Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03541551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*